90000
1-(对甲苯基)乙醇
≥97.0% (GC)
别名:
4,α-二甲基苄醇, 二甲基苄醇
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C9H12O
化学文摘社编号:
分子量:
136.19
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
208-637-8
Beilstein/REAXYS Number:
1857562
MDL number:
产品名称
1-(对甲苯基)乙醇, ≥97.0% (GC)
InChI
1S/C9H12O/c1-7-3-5-9(6-4-7)8(2)10/h3-6,8,10H,1-2H3
InChI key
JESIHYIJKKUWIS-UHFFFAOYSA-N
SMILES string
CC(O)c1ccc(C)cc1
assay
≥97.0% (GC)
form
liquid
refractive index
n20/D 1.523
bp
218-220 °C (lit.)
density
0.987 g/mL at 20 °C (lit.)
functional group
hydroxyl
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
224.6 °F - closed cup
flash_point_c
107 °C - closed cup
ppe
Eyeshields, Gloves
法规信息
新产品
此项目有
Tahereh Mirmajidi et al.
International journal of pharmaceutics, 596, 120213-120213 (2021-01-26)
Wound healing is a complicated process that takes a long time to complete. The three-layer nanofiber wound dressing containing melatonin is highly expected to show remarkable wound repair by reducing the wound healing time. In this study, chitosan (Cs)-polycaprolactone (PCL)/
Siqi Huang et al.
International journal of biological macromolecules, 137, 939-947 (2019-07-08)
The severe preparation process, poor swelling properties and mechanical properties of traditional cellulose and polyvinyl alcohol (PVA) composite hydrogels heavily limited their practical applications. To solve these issues, we use long-chain hydroxyethyl celluloses (HECs) as framework backbones, short-chain PVAs as
Siqi Huang et al.
Carbohydrate polymers, 223, 115080-115080 (2019-08-21)
In this study, hydroxyethyl cellulose (HEC) and polyvinyl alcohol (PVA) as the framework, borax as the cross-linker, and biomass lignin from pulping black liquors and biorefinery as the plasticizer were used to synthesize the lignin-based HEC-PVA (LCP) self-healing conductive hydrogel
Napoleon-Nikolaos Vrettos et al.
Pharmaceutical development and technology, 26(3), 349-361 (2021-01-13)
Hypertension is one of the most common chronic cardiovascular disorders. Sustained-release formulations are developed to maintain drug therapeutic levels throughout the treatment of hypertension, to promote patient compliance and improve patient outcomes. We have developed and tested in in vivo trials
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持